Clinical trials
Overweight or Obese clinical trials
Below are recruiting overweight or obese clinical trials, each written for real people, not researchers. We’re tracking 1,530 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07541677Recruiting
Muscle Loss and Obesity: Understanding Risk Factors
This study examines how muscle loss (sarcopenia) relates to obesity in adults seeking weight-loss treatment. Researchers will assess your muscle strength and physical function to identify risk factors, which could help improve future obesity care.
SingaporeAges 21–100 - NCT07559227Recruiting
How obesity affects gut health and blood vessel function
This study compares people with normal weight to people with obesity who are otherwise healthy to understand how body weight affects gut bacteria, immune function, and blood vessel health. Results may help explain why some people with obesity stay healthier than others.
Muncie, IndianaAges 18–55 - NCT07564414RecruitingPhase 3
Weight Loss Study Comparing Two Doses of CagriSema
This study tests whether a new combination medication called CagriSema (in two different doses) helps people with obesity lose weight. You may qualify if you're 18 or older, have a BMI of 35 or higher, and either don't have type 2 diabetes or have it well-controlled.
Birmingham, AlabamaAges 18 years+ - NCT07576478Recruiting
Balloon Blowing Therapy for Obese Children
This trial tests whether blowing up balloons can help obese children breathe easier and feel better. The study measures changes in breathing, shortness of breath, and quality of life over the course of the treatment.
Peshawar, Khyber PakhtunkhwaAges 6–12 - NCT07618741Recruiting
Improving AF Ablation Outcomes in Patients with Obesity
This study tests whether special care strategies can help obese patients have better results after a catheter ablation procedure for atrial fibrillation (a heart rhythm problem). Catheter ablation uses heat or cold to fix the irregular heartbeats.
TaipeiAges 20 years+ - NCT07627919Recruiting
Strength training and high-protein diet for frail older women
This study tests whether combining resistance exercises with a protein-rich diet can improve muscle strength and overall function in older women with weak muscles. You would attend supervised workouts and follow a specific eating plan for several weeks.
El-Sheikh Zayed CityAges 60–70 - NCT07633639Recruiting
GLP-1 Medicine After Weight-Loss Surgery in Chinese Patients
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
BeijingAges 18–60 - NCT07652333Recruiting
Strength training for muscle and mind on obesity medication
This study tests whether strength training can help adults taking new obesity medications (like Wegovy or Ozempic) maintain muscle and improve mental health. You would start the medication after your first study visit.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07656727RecruitingPhase 2
A study of BGE-102 for obesity and heart risk
This trial tests an experimental drug called BGE-102 in people with obesity and signs of inflammation. It aims to see if the drug can help reduce body weight and improve heart health. Participants must be willing to keep a stable diet and exercise routine.
Chandler, ArizonaAges 18 years+ - NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Madrid, MadridAges 50–75 - NCT07640139Enrolling by invitation
Study of Weight-Loss Medications' Health and Cost Effects
This research study looks at how obesity medications affect people's health outcomes and healthcare costs. Researchers will track employees and their family members covered by participating Indiana employers to understand whether these medications help improve conditions like diabetes and heart health.
Indianapolis, IndianaAges 18–64 - NCT07598981Enrolling by invitation
Obesity Medication Safety and Effectiveness Registry
This registry tracks how well obesity medications work and their safety in real-world use. You'll share your health information and experiences with your obesity medication over time to help doctors understand what works best for different people.
Waltham, MassachusettsAges 18 years+ - NCT07494253Enrolling by invitation
Mulberry leaf extract for blood sugar after meals in obese youth
This study tests if a mulberry leaf extract (Reducose) can help lower blood sugar spikes after meals in children and teenagers with obesity. The goal is to see if a natural supplement can improve glucose control.
BariAges 6–16 - NCT07419503Enrolling by invitation
Healthy lifestyle program for overweight children
This study evaluates a healthy lifestyle program for children ages 4 to 12 who are overweight. It looks at how well the program works and gathers feedback from children, parents, and program providers.
Rotterdam, South HollandAges 4–12 - NCT07404150Enrolling by invitation
Lifestyle program for women with obesity
This trial tests a year-long lifestyle program designed to help women with obesity improve their eating, well-being, and health habits. You will meet with a group for support and guidance.
Calgary, AlbertaAges 35–75 - NCT07156578Enrolling by invitationPhase 2
Long-term bivamelagon for hypothalamic obesity
This long-term study tests a new drug, bivamelagon, for people with hypothalamic obesity. It's for those who already completed a similar study and tolerated the drug well.
Aurora, ColoradoAges 12 years+ - NCT07062315Enrolling by invitation
Timed eating based on your body clock for belly fat and health
This study tests if eating only during certain hours that match your natural sleep-wake pattern helps reduce belly fat and improve health in adults who are not very active and have extra weight around the middle.
Hong KongAges 18–65 - NCT07057310Enrolling by invitationPhase 4
Weight Loss Drug for Postmenopausal Women With Obesity
This study tests a GLP-1 agonist medication (like Ozempic) to help postmenopausal women lose weight and improve physical and blood vessel health. It focuses on women aged 46–60 with obesity.
Jacksonville, FloridaAges 46–60 - NCT07001865Enrolling by invitation
Effects of healthy obesity on liver and uric acid risks
This study looks at people who are metabolically healthy but overweight or obese, and how that affects their risk of developing fatty liver disease (MASLD) or high uric acid levels (hyperuricemia). It aims to see if 'healthy' obesity still carries hidden health risks.
NingboAges 18–100 - NCT06989281Enrolling by invitation
Lifestyle medicine study for UAB patients
This study tests a lifestyle program offered in primary care to help patients manage conditions like diabetes, high blood pressure, high cholesterol, or psoriatic arthritis. It aims to see if this approach can improve health and well-being.
Birmingham, AlabamaAges 18–89 - NCT06946329Enrolling by invitation
Water exercise for knee pain in obese men
This study tests whether a supervised water exercise program (called WATERinMOTION) can reduce knee pain and improve movement in obese men with knee osteoarthritis. It may help if you are looking for a gentle, joint-friendly way to manage your knee pain.
Zahedan, Sistan and BaluchestanAges 45–65 - NCT06916364Enrolling by invitation
Airway rod for intubation in adults with obesity
This trial tests if a special rod helps place a breathing tube more easily in adults with obesity who are having planned surgery. It could make the procedure safer and more comfortable.
Houston, TexasAges 18 years+ - NCT06907212Enrolling by invitation
Study of fat cell changes in obesity
This study looks at how fat cells change in people with obesity. It involves a small tissue sample (biopsy) and may help us understand more about weight-related health.
CopenhagenAges 18 years+ - NCT06888570Enrolling by invitation
Liver health study for children & young adults with Down syndrome
This study looks at how eating patterns and body composition relate to fatty liver in children and young adults with Trisomy 21 (Down syndrome) or other genetic intellectual disabilities. It may help understand who is at risk and how to prevent liver problems.
Madrid, MadridAges 5–22
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for overweight or obese?
- Yes. Clin2 currently lists 1,530 recruiting overweight or obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a overweight or obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a overweight or obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.